Profile

Cover photo
114 followers|7,970 views
AboutPostsPhotosVideos

Stream

BioTime

Shared publicly  - 
 
LifeMap Sciences Announces the Next Generation of GeneCards® - Version 4.0

> The New GeneCards® Powers LifeMap’s NGS Analysis and Interpretation Platform
> Enables Rapid Integration with Partners in the NGS Storage, Analysis and Interpretation Markets and Will Allow for Partnering Opportunities
>New User Interface, Functionality and Application Programming Interface (“API”) API Provide Improved Offering for Academia, Biopharma and Diagnostic Companies
1
Add a comment...

BioTime

Shared publicly  - 
 
Asterias Biotherapeutics Added To Russell 2000, Russell 3000, Russell Global and Russell Microcap Indexes $AST http://bit.ly/1FNFe82
1
Add a comment...

BioTime

Shared publicly  - 
 
William Annett Named Chief Executive Officer of OncoCyte Corporation

-- Appointment Brings Commercial, Operational, and Financial Expertise from Several Companies, Including Genentech and Accenture
-- Biotechnology and Diagnostics Industry Leader to Focus on Later Stages of Clinical Trials and Commercialization of Three Non-Invasive Cancer Diagnostic Products
-- All Clinical Trials Progressing to Later Stages; Interim Bladder Cancer Diagnostic Clinical Results Announced Earlier This Year in Collaboration with a Leading Medical Institution
1
Add a comment...

BioTime

Shared publicly  - 
 
BioTime to Present at the Jefferies 2015 Global Healthcare Conference http://bit.ly/1F26vnY
1
Add a comment...

BioTime

Shared publicly  - 
 
BioTime company OncoCyte completes equity financing round http://bit.ly/1K8ETUN $BTX
1
Add a comment...

BioTime

Shared publicly  - 
 
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.6 Million Grant From Israel’s Office of the Chief Scientist
1
Add a comment...
Have them in circles
114 people
ashkir john's profile photo
Evans Kathleen's profile photo
Alma Huffman's profile photo
Angel Pupo's profile photo
balluch Sharon's profile photo
Sarah Mcguffey's profile photo
Jimmy Scott's profile photo
Meghan Cooper's profile photo
Kami Brady's profile photo

BioTime

Shared publicly  - 
 
BioTime company OncoCyte Appoints Andy Arno to Board of Directors; brings 30 yrs of capital markets experience
$BTX
OncoCyte Announces Appointment of Andy Arno to Board of Directors. -- Appointment Brings 30 Years of Strategic Advisory and Capital Markets Experience. -- OncoCyte is Advancing Three Non-invasive Cancer Diagnostics Through Clinical Trials. ALAMEDA, Calif. --(BUSINESS WIRE)--Jul.
1
Add a comment...

BioTime

Shared publicly  - 
 
We are pleased to announce the unveiling of our all-new corporate website, at www.biotimeinc.com.
Specifically redesigned to improve the website user's overall experience, the new site features easier navigation, updated content, and a exciting and engaging look and feel. Simply put, the new site offers much stronger corporate visibility to help share our story with a much larger audience. 
Visitors to the site will find a user friendly interface, enabling deeper understanding of BioTime's depth, passion, and unrivaled commitment to building shareholder value through the development of novel, cell-based therapies and non-invasive molecular diagnostics to patients with serious diseases and degenerative conditions for which there presently are no cures.
1
Add a comment...

BioTime

Shared publicly  - 
 
BioTime company Asterias Biotherapeutics Announced First Patient Treated in Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury http://bit.ly/1GlEPhV
1
Add a comment...

BioTime

Shared publicly  - 
 
BioTime company OncoCyte reports that its Collaborators at The Wistar Institute Present Positive Clinical Interim Results of Blood-Based Diagnostic Test for Non-Invasive Detection of Lung Cancer

> Data Presented at 2015 American Thoracic Society International Conference
1
Add a comment...

BioTime

Shared publicly  - 
 
BioTime company Asterias Biotherapeutics Announces Availability of Abstract with Phase 2 Clinical Data on Cancer Vaccine AST-VAC1 in Acute Myelogenous Leukemia (AML)

>Data to be Featured in Oral Presentation at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting  http://bit.ly/1E7KKBl
1
Add a comment...

BioTime

Shared publicly  - 
 
BioTime company LifeMap Solutions pens inaugural post on official Apple ResearchKit blog https://lnkd.in/eFKFaEu
May 7, 2015. Preliminary User-Engagement Learning from our ResearchKit-Enabled Asthma Health App. With our partner Mount Sinai, we launched Asthma Health, one of the inaugural apps built on ResearchKit. The objective of the study is to gain greater insight into triggers of the disease and, ...
1
Add a comment...
People
Have them in circles
114 people
ashkir john's profile photo
Evans Kathleen's profile photo
Alma Huffman's profile photo
Angel Pupo's profile photo
balluch Sharon's profile photo
Sarah Mcguffey's profile photo
Jimmy Scott's profile photo
Meghan Cooper's profile photo
Kami Brady's profile photo
Contact Information
Contact info
Phone
(510) 521-3390
Story
Tagline
Developing stem cell-based therapies and products in the area of regenerative medicine
Introduction
BioTime, a biotechnology company headquartered in the San Francisco Bay Area, is focused on biomedical research and product development in regenerative medicine.